Question group

Government Office for Life Sciences - NHS Innovation, Uptake and Access

Questions in this group:

Government Office for Life Sciences - NHS Innovation, Uptake and Access Evidence on whether the commercial environment has a material impact on launch prioritisation for new drugs. Department for Science, Innovation & Technology, 2024

See details

Government Office for Life Sciences - NHS Innovation, Uptake and Access We would like to understand the relationship between drug launch / supply of new drugs and the broader commercial environment, including price regulation and other cost control measures. Department for Science, Innovation & Technology, 2024

See details

Government Office for Life Sciences - NHS Innovation, Uptake and Access Detailed data on the price per QALY associated with each medicine and medical technology purchased by the NHS. Department for Science, Innovation & Technology, 2024

See details

Government Office for Life Sciences - NHS Innovation, Uptake and Access Detailed data on uptake and access of medicines and medical technologies at the level of each commissioning unit. Department for Science, Innovation & Technology, 2024

See details

Government Office for Life Sciences - NHS Innovation, Uptake and Access Detailed data on the dates of regulatory approval and cost-effectiveness appraisal of medicines and medical technologies. Department for Science, Innovation & Technology, 2024

See details

Government Office for Life Sciences - NHS Innovation, Uptake and Access Estimates of the benefit and impact of introducing new technologies and therapeutics to the NHS. Department for Science, Innovation & Technology, 2024

See details

Government Office for Life Sciences - NHS Innovation, Uptake and Access Reliable estimates of the relative productivity of the different factors in the health production function for the NHS. Department for Science, Innovation & Technology, 2024

See details

1